Drug intelligence / Profile preview

Vitramyn

Development stage
Unknown
Lead developer
Puretek
Modality
Small Molecules
Administration
Oral
01

Overview

Vitramyn is a comprehensive multivitamin and multimineral supplement marketed by Puretek Corporation under the DermacinRx brand. It is formulated to provide essential micronutrients that serve as cofactors for a wide range of physiological processes, including energy metabolism, DNA synthesis, and antioxidant defense. The product contains a broad spectrum of vitamins, including Vitamin A, Vitamin C, Vitamin D3, Vitamin E, and the B-complex (thiamine, riboflavin, niacin, B6, folate, B12, biotin, and pantothenic acid), alongside essential minerals such as calcium, iron, magnesium, zinc, and selenium. Vitramyn is typically used to treat or prevent nutritional deficiencies and is often included as adjunctive therapy in clinical kits for conditions such as wound care, pain management, and migraine support to optimize patient recovery and general wellness.

Brand names
VitramynDermacinRx Vitramyn
02

Targets

VDR (Vitamin D receptor)RAR (Retinoic acid receptor)

Beyond the preview

Go deeper on Vitramyn.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitramyn.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call